Which company did well over launching new drugs in first half?
When it comes to new drug launches made by multinational pharmaceutical companies in the first half of the year, Boehringer Ingelheim Korea and Lilly Korea were known to lead, and the most common one was anticancer drugs.
According to the analysis result of multinational companies’ products laun...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
